Greg Amira, Purple Heart Iraq Veteran and 9/11 survivor, became the 900,000th Veteran to join the Million Veteran Program.
A Veteran was interested in losing weight. Then his VA dietitian discovered he had non-alcoholic fatty liver disease (NAFLD). Here’s what she did.
Cardiothoracic surgeons at Houston VA performed their first heart transplant showing VA's expanded capacity to care for Veterans.
National VA Research Week is May 16-20, 2022. This year's theme is "Science in Service of Veterans."
Today’s #VeteranOfTheDay is Marine Corps and Army Veteran Dominic J. Hall, who served in Japan and in Afghanistan.
One easy way to be proactive with cancer preventionis to discuss cancer-preventing vaccines with your primary care provider.
Throughout its history of more than 75 years, VA has funded critical research that has led to many medical advancements instrumental to the agency’s primary goal: to honor America’s Veterans by providing exceptional health care that improves their health and well-being.
Father and son doctors at Salem VA began their journeys into medicine from different starting points. Son, a Navy Veteran: “VA? I’d be working with dad!”
A recent VA Houston study published in Alimentary Pharmacology and Therapeutics found that hepatitis C positive organs are a safe and effective option for most transplant candidates. Newer antiviral drugs have made it possible for patients to be successfully treated for hepatitis C infections transmitted via organ transplant.
Called bacteriophages, or phages, these viruses cannot infect human cells. Phages are incredibly diverse and exist everywhere in the environment, including in our bodies; in fact, humans contain more phages than human cells.
At the Dallas VA, a new weapon in the fight against cancer in the Veteran population was recently unveiled. Selective Internal Radiation Therapy (SIRT) was performed on a Veteran with liver cancer.
VA has tested 85% of Veterans born 1945-1965 (at higher risk for hepatitis C) and more than 75% of Veterans age 18-79 for hepatitis C.